Bivalirudine Hikma 250 mg poeder voor concentraat voor oplossing voor injectie/infusie
As listed in the register: Bivalirudine Hikma 250 mg poeder voor concentraat voor oplossing voor injectie/infusie
250 mg · poeder voor concentraat voor oplossing voor injectie / infusie
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Bivalirudine X-Trifluoracetaat
- Used in
- Blood, clotting and anaemia
- Made by
- Hikma Farmaceutica (Portugal), S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
Spain3 matching products
CanadaNo exact match for this strength and form
Details
| Made by | Hikma Farmaceutica (Portugal), S.A. |
|---|---|
| Active substance | Bivalirudine X-Trifluoracetaat |
| Used in | Blood, clotting and anaemia |
| Strength | 250 mg |
| Form | poeder voor concentraat voor oplossing voor injectie / infusie |
| Classification | B01AE06 · Blood, clotting and anaemia |
| Route | intraveneus gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| RVG | 124387 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).